BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29548926)

  • 1. The potential of aptamers for cancer research.
    Zhou Z; Liu M; Jiang J
    Anal Biochem; 2018 May; 549():91-95. PubMed ID: 29548926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
    Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
    Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging cancer targets for aptamer delivery.
    de Franciscis V
    Biochimie; 2018 Feb; 145():45-52. PubMed ID: 28962871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
    Zhu H; Li J; Zhang XB; Ye M; Tan W
    ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted drug delivery with aptamers.
    Zhang Y; Hong H; Cai W
    Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid aptamers: an emerging frontier in cancer therapy.
    Zhu G; Ye M; Donovan MJ; Song E; Zhao Z; Tan W
    Chem Commun (Camb); 2012 Nov; 48(85):10472-80. PubMed ID: 22951893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-guided nanomedicines for anticancer drug delivery.
    Alshaer W; Hillaireau H; Fattal E
    Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outlook for aptamers after twenty five years.
    Tsae PK; DeRosa MC
    Curr Top Med Chem; 2015; 15(12):1153-9. PubMed ID: 25910491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers: molecular tools for medical diagnosis.
    Ozalp VC; Kavruk M; Dilek O; Bayrac AT
    Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-aptamer bioconjugates for cancer targeting.
    Farokhzad OC; Karp JM; Langer R
    Expert Opin Drug Deliv; 2006 May; 3(3):311-24. PubMed ID: 16640493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A basic insight into aptamer-drug conjugates (ApDCs).
    Xuan W; Peng Y; Deng Z; Peng T; Kuai H; Li Y; He J; Jin C; Liu Y; Wang R; Tan W
    Biomaterials; 2018 Nov; 182():216-226. PubMed ID: 30138784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-based targeted therapy.
    Zhu G; Chen X
    Adv Drug Deliv Rev; 2018 Sep; 134():65-78. PubMed ID: 30125604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.
    Camorani S; Crescenzi E; Fedele M; Cerchia L
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):263-277. PubMed ID: 29574128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.